Table of Contents Chapter 1 Overview of Hospital Infection Therapeutics 1.1 Definition of Hospital Infection Therapeutics in This Report 1.2 Commercial Types of Hospital Infection Therapeutics 1.2.1 Antibacterial Drugs 1.2.2 Antiviral Drugs 1.2.3 Antifungal Drugs 1.3 Downstream Application of Hospital Infection Therapeutics 1.3.1 Hospital-Acquired Pneumonia 1.3.2 Urinary Tract Infections 1.3.3 Gastrointestinal Disorders 1.3.4 Bloodstream Infections 1.3.5 Surgical Site Infections 1.3.6 Other Hospital Infections 1.4 Development History of Hospital Infection Therapeutics 1.5 Market Status and Trend of Hospital Infection Therapeutics 2013-2023 1.5.1 Global Hospital Infection Therapeutics Market Status and Trend 2013-2023 1.5.2 Regional Hospital Infection Therapeutics Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Hospital Infection Therapeutics 2013-2017 2.2 Sales Market of Hospital Infection Therapeutics by Regions 2.2.1 Sales Volume of Hospital Infection Therapeutics by Regions 2.2.2 Sales Value of Hospital Infection Therapeutics by Regions 2.3 Production Market of Hospital Infection Therapeutics by Regions 2.4 Global Market Forecast of Hospital Infection Therapeutics 2018-2023 2.4.1 Global Market Forecast of Hospital Infection Therapeutics 2018-2023 2.4.2 Market Forecast of Hospital Infection Therapeutics by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Hospital Infection Therapeutics by Types 3.2 Sales Value of Hospital Infection Therapeutics by Types 3.3 Market Forecast of Hospital Infection Therapeutics by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Hospital Infection Therapeutics by Downstream Industry 4.2 Global Market Forecast of Hospital Infection Therapeutics by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Hospital Infection Therapeutics Market Status by Countries 5.1.1 North America Hospital Infection Therapeutics Sales by Countries (2013-2017) 5.1.2 North America Hospital Infection Therapeutics Revenue by Countries (2013-2017) 5.1.3 United States Hospital Infection Therapeutics Market Status (2013-2017) 5.1.4 Canada Hospital Infection Therapeutics Market Status (2013-2017) 5.1.5 Mexico Hospital Infection Therapeutics Market Status (2013-2017) 5.2 North America Hospital Infection Therapeutics Market Status by Manufacturers 5.3 North America Hospital Infection Therapeutics Market Status by Type (2013-2017) 5.3.1 North America Hospital Infection Therapeutics Sales by Type (2013-2017) 5.3.2 North America Hospital Infection Therapeutics Revenue by Type (2013-2017) 5.4 North America Hospital Infection Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Hospital Infection Therapeutics Market Status by Countries 6.1.1 Europe Hospital Infection Therapeutics Sales by Countries (2013-2017) 6.1.2 Europe Hospital Infection Therapeutics Revenue by Countries (2013-2017) 6.1.3 Germany Hospital Infection Therapeutics Market Status (2013-2017) 6.1.4 UK Hospital Infection Therapeutics Market Status (2013-2017) 6.1.5 France Hospital Infection Therapeutics Market Status (2013-2017) 6.1.6 Italy Hospital Infection Therapeutics Market Status (2013-2017) 6.1.7 Russia Hospital Infection Therapeutics Market Status (2013-2017) 6.1.8 Spain Hospital Infection Therapeutics Market Status (2013-2017) 6.1.9 Benelux Hospital Infection Therapeutics Market Status (2013-2017) 6.2 Europe Hospital Infection Therapeutics Market Status by Manufacturers 6.3 Europe Hospital Infection Therapeutics Market Status by Type (2013-2017) 6.3.1 Europe Hospital Infection Therapeutics Sales by Type (2013-2017) 6.3.2 Europe Hospital Infection Therapeutics Revenue by Type (2013-2017) 6.4 Europe Hospital Infection Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Hospital Infection Therapeutics Market Status by Countries 7.1.1 Asia Pacific Hospital Infection Therapeutics Sales by Countries (2013-2017) 7.1.2 Asia Pacific Hospital Infection Therapeutics Revenue by Countries (2013-2017) 7.1.3 China Hospital Infection Therapeutics Market Status (2013-2017) 7.1.4 Japan Hospital Infection Therapeutics Market Status (2013-2017) 7.1.5 India Hospital Infection Therapeutics Market Status (2013-2017) 7.1.6 Southeast Asia Hospital Infection Therapeutics Market Status (2013-2017) 7.1.7 Australia Hospital Infection Therapeutics Market Status (2013-2017) 7.2 Asia Pacific Hospital Infection Therapeutics Market Status by Manufacturers 7.3 Asia Pacific Hospital Infection Therapeutics Market Status by Type (2013-2017) 7.3.1 Asia Pacific Hospital Infection Therapeutics Sales by Type (2013-2017) 7.3.2 Asia Pacific Hospital Infection Therapeutics Revenue by Type (2013-2017) 7.4 Asia Pacific Hospital Infection Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Hospital Infection Therapeutics Market Status by Countries 8.1.1 Latin America Hospital Infection Therapeutics Sales by Countries (2013-2017) 8.1.2 Latin America Hospital Infection Therapeutics Revenue by Countries (2013-2017) 8.1.3 Brazil Hospital Infection Therapeutics Market Status (2013-2017) 8.1.4 Argentina Hospital Infection Therapeutics Market Status (2013-2017) 8.1.5 Colombia Hospital Infection Therapeutics Market Status (2013-2017) 8.2 Latin America Hospital Infection Therapeutics Market Status by Manufacturers 8.3 Latin America Hospital Infection Therapeutics Market Status by Type (2013-2017) 8.3.1 Latin America Hospital Infection Therapeutics Sales by Type (2013-2017) 8.3.2 Latin America Hospital Infection Therapeutics Revenue by Type (2013-2017) 8.4 Latin America Hospital Infection Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Hospital Infection Therapeutics Market Status by Countries 9.1.1 Middle East and Africa Hospital Infection Therapeutics Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Hospital Infection Therapeutics Revenue by Countries (2013-2017) 9.1.3 Middle East Hospital Infection Therapeutics Market Status (2013-2017) 9.1.4 Africa Hospital Infection Therapeutics Market Status (2013-2017) 9.2 Middle East and Africa Hospital Infection Therapeutics Market Status by Manufacturers 9.3 Middle East and Africa Hospital Infection Therapeutics Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Hospital Infection Therapeutics Sales by Type (2013-2017) 9.3.2 Middle East and Africa Hospital Infection Therapeutics Revenue by Type (2013-2017) 9.4 Middle East and Africa Hospital Infection Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Hospital Infection Therapeutics 10.1 Global Economy Situation and Trend Overview 10.2 Hospital Infection Therapeutics Downstream Industry Situation and Trend Overview Chapter 11 Hospital Infection Therapeutics Market Competition Status by Major Manufacturers 11.1 Production Volume of Hospital Infection Therapeutics by Major Manufacturers 11.2 Production Value of Hospital Infection Therapeutics by Major Manufacturers 11.3 Basic Information of Hospital Infection Therapeutics by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Hospital Infection Therapeutics Major Manufacturer 11.3.2 Employees and Revenue Level of Hospital Infection Therapeutics Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Hospital Infection Therapeutics Major Manufacturers Introduction and Market Data 12.1 Sanofi 12.1.1 Company profile 12.1.2 Representative Hospital Infection Therapeutics Product 12.1.3 Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Sanofi 12.2 Pfizer 12.2.1 Company profile 12.2.2 Representative Hospital Infection Therapeutics Product 12.2.3 Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Pfizer 12.3 Merck 12.3.1 Company profile 12.3.2 Representative Hospital Infection Therapeutics Product 12.3.3 Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Merck 12.4 Bayer 12.4.1 Company profile 12.4.2 Representative Hospital Infection Therapeutics Product 12.4.3 Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Bayer 12.5 Johnson & Johnson 12.5.1 Company profile 12.5.2 Representative Hospital Infection Therapeutics Product 12.5.3 Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Johnson & Johnson 12.6 AstraZeneca 12.6.1 Company profile 12.6.2 Representative Hospital Infection Therapeutics Product 12.6.3 Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of AstraZeneca 12.7 Actavis 12.7.1 Company profile 12.7.2 Representative Hospital Infection Therapeutics Product 12.7.3 Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Actavis 12.8 Bristol-Myers Squibb Company 12.8.1 Company profile 12.8.2 Representative Hospital Infection Therapeutics Product 12.8.3 Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb Company 12.9 Cubist Pharmaceuticals 12.9.1 Company profile 12.9.2 Representative Hospital Infection Therapeutics Product 12.9.3 Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Cubist Pharmaceuticals 12.10 GlaxoSmithKline 12.10.1 Company profile 12.10.2 Representative Hospital Infection Therapeutics Product 12.10.3 Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of GlaxoSmithKline Chapter 13 Upstream and Downstream Market Analysis of Hospital Infection Therapeutics 13.1 Industry Chain of Hospital Infection Therapeutics 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Hospital Infection Therapeutics 14.1 Cost Structure Analysis of Hospital Infection Therapeutics 14.2 Raw Materials Cost Analysis of Hospital Infection Therapeutics 14.3 Labor Cost Analysis of Hospital Infection Therapeutics 14.4 Manufacturing Expenses Analysis of Hospital Infection Therapeutics Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Antibacterial Drugs Table Advantage and Disadvantage of Antiviral Drugs Table Advantage and Disadvantage of Antifungal Drugs Table Sales Volume of Hospital Infection Therapeutics by Regions 2013-2017 Table Sales Value of Hospital Infection Therapeutics by Regions 2013-2017 Table Production Volume of Hospital Infection Therapeutics by Regions 2013-2017 Table Global Sales Volume of Hospital Infection Therapeutics by Regions 2018-2023 Table Global Sales Value of Hospital Infection Therapeutics by Regions 2018-2023 Table Global Production Volume of Hospital Infection Therapeutics by Regions 2018-2023 Table Sales Volume of Hospital Infection Therapeutics by Types 2013-2017 Table Sales Value of Hospital Infection Therapeutics by Types 2013-2017 Table Sales Volume Forecast of Hospital Infection Therapeutics by Types 2018-2023 Table Sales Value Forecast of Hospital Infection Therapeutics by Types 2018-2023 Table Sales Volume of Hospital Infection Therapeutics by Downstream Industry 2013-2017 Table Sales Volume Forecast of Hospital Infection Therapeutics by Downstream Industry 2018-2023 Table North America Hospital Infection Therapeutics Sales by Countries (2013-2017) Table North America Hospital Infection Therapeutics Sales Share by Countries (2013-2017) Table North America Hospital Infection Therapeutics Revenue by Countries (2013-2017) Table North America Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2017) Table North America Hospital Infection Therapeutics Sales by Type (2013-2017) Table North America Hospital Infection Therapeutics Sales Share by Type (2013-2017) Table North America Hospital Infection Therapeutics Revenue by Type (2013-2017) Table North America Hospital Infection Therapeutics Revenue Share by Type (2013-2017) Table North America Hospital Infection Therapeutics Sales by Downstream Industry (2013-2017) Table North America Hospital Infection Therapeutics Sales Share by Downstream Industry (2013-2017) Table Europe Hospital Infection Therapeutics Sales by Countries (2013-2017) Table Europe Hospital Infection Therapeutics Sales Share by Countries (2013-2017) Table Europe Hospital Infection Therapeutics Revenue by Countries (2013-2017) Table Europe Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2017) Table Europe Hospital Infection Therapeutics Sales by Type (2013-2017) Table Europe Hospital Infection Therapeutics Sales Share by Type (2013-2017) Table Europe Hospital Infection Therapeutics Revenue by Type (2013-2017) Table Europe Hospital Infection Therapeutics Revenue Share by Type (2013-2017) Table Europe Hospital Infection Therapeutics Sales by Downstream Industry (2013-2017) Table Europe Hospital Infection Therapeutics Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Hospital Infection Therapeutics Sales by Countries (2013-2017) Table Asia Pacific Hospital Infection Therapeutics Sales Share by Countries (2013-2017) Table Asia Pacific Hospital Infection Therapeutics Revenue by Countries (2013-2017) Table Asia Pacific Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2017) Table Asia Pacific Hospital Infection Therapeutics Sales by Type (2013-2017) Table Asia Pacific Hospital Infection Therapeutics Sales Share by Type (2013-2017) Table Asia Pacific Hospital Infection Therapeutics Revenue by Type (2013-2017) Table Asia Pacific Hospital Infection Therapeutics Revenue Share by Type (2013-2017) Table Asia Pacific Hospital Infection Therapeutics Sales by Downstream Industry (2013-2017) Table Asia Pacific Hospital Infection Therapeutics Sales Share by Downstream Industry (2013-2017) Table Latin America Hospital Infection Therapeutics Sales by Countries (2013-2017) Table Latin America Hospital Infection Therapeutics Sales Share by Countries (2013-2017) Table Latin America Hospital Infection Therapeutics Revenue by Countries (2013-2017) Table Latin America Hospital Infection Therapeutics Revenue Market Share by Countries (2013-2017) Table Latin America Hospital Infection Therapeutics Sales by Type (2013-2017) Table Latin America Hospital Infection Therapeutics Sales Share by Type (2013-2017) Table Latin America Hospital Infection Therapeutics Revenue by Type (2013-2017) Table Latin America Hospital Infection Therapeutics Revenue Share by Type (2013-2017) Table Latin America Hospital Infection Therapeutics Sales by Downstream Industry (2013-2017) Table Latin America Hospital Infection Therapeutics Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Hospital Infection Therapeutics Sales by Regions (2013-2017) Table Middle East and Africa Hospital Infection Therapeutics Sales Share by Regions (2013-2017) Table Middle East and Africa Hospital Infection Therapeutics Revenue by Regions (2013-2017) Table Middle East and Africa Hospital Infection Therapeutics Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Hospital Infection Therapeutics Sales by Type (2013-2017) Table Middle East and Africa Hospital Infection Therapeutics Sales Share by Type (2013-2017) Table Middle East and Africa Hospital Infection Therapeutics Revenue by Type (2013-2017) Table Middle East and Africa Hospital Infection Therapeutics Revenue Share by Type (2013-2017) Table Middle East and Africa Hospital Infection Therapeutics Sales by Downstream Industry (2013-2017) Table Middle East and Africa Hospital Infection Therapeutics Sales Share by Downstream Industry (2013-2017) Table Production Volume of Hospital Infection Therapeutics by Major Manufacturers 2013-2017 Table Production Value of Hospital Infection Therapeutics by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Hospital Infection Therapeutics Major Manufacturer Table Employees and Revenue Level of Hospital Infection Therapeutics Major Manufacturer Table Representative Hospital Infection Therapeutics Product One of Sanofi Table Representative Hospital Infection Therapeutics Product Two of Sanofi Table Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Sanofi 2013-2017 Table Representative Hospital Infection Therapeutics Product One of Pfizer Table Representative Hospital Infection Therapeutics Product Two of Pfizer Table Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017 Table Representative Hospital Infection Therapeutics Product One of Merck Table Representative Hospital Infection Therapeutics Product Two of Merck Table Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Merck 2013-2017 Table Representative Hospital Infection Therapeutics Product One of Bayer Table Representative Hospital Infection Therapeutics Product Two of Bayer Table Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Bayer 2013-2017 Table Representative Hospital Infection Therapeutics Product One of Johnson & Johnson Table Representative Hospital Infection Therapeutics Product Two of Johnson & Johnson Table Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2013-2017 Table Representative Hospital Infection Therapeutics Product One of AstraZeneca Table Representative Hospital Infection Therapeutics Product Two of AstraZeneca Table Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of AstraZeneca 2013-2017 Table Representative Hospital Infection Therapeutics Product One of Actavis Table Representative Hospital Infection Therapeutics Product Two of Actavis Table Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Actavis 2013-2017 Table Representative Hospital Infection Therapeutics Product One of Bristol-Myers Squibb Company Table Representative Hospital Infection Therapeutics Product Two of Bristol-Myers Squibb Company Table Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb Company 2013-2017 Table Representative Hospital Infection Therapeutics Product One of Cubist Pharmaceuticals Table Representative Hospital Infection Therapeutics Product Two of Cubist Pharmaceuticals Table Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of Cubist Pharmaceuticals 2013-2017 Table Representative Hospital Infection Therapeutics Product One of GlaxoSmithKline Table Representative Hospital Infection Therapeutics Product Two of GlaxoSmithKline Table Hospital Infection Therapeutics Sales, Revenue, Price and Gross Margin of GlaxoSmithKline 2013-2017